Networks & Consortia — Oxford Cancer

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Networks & Consortia

Oxford Lymphoid Disorders Study Group

Pancreatic Cancer highlighted in the body

PancrImmune

Oxford's Pancreatic Network

Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre

The international partnership for developing a gastrointestinal cancer plan

S:CORT

Stratification in Colorectal Cancer

Colorectal cancer being highlighted in the body

ACRCelerate

Oxford's Colorectal Cancer Stratified Medicine Network

ART-NET

Advanced Radiotherapy Technologies Network

Prostate cancer being highlighted in the body

EHNBPCCG

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer

European Prospective Investigation into Cancer and Nutrition (EPIC)

Immunotherapy drugs attacking a cancer cell

Southampton Immune Accelerator

Improving Immunotherapy treatment for cancer patients

National Consortium for Intelligent Medical Imaging (NCIMI)

Driving innovation in the use of artificial intelligence (AI) for improved diagnosis and treatment in cancer

PathLAKE

Pathology image data Lake for Education, Analytics and Discovery

National Cancer Imaging Translational Accelerator (NCITA)

A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers